rs2306283
A SNP in the SLCO1B1 gene on chromosome 12. Its most notable genotype is A;A: common in clinvar
- Gene
- SLCO1B1
- Location
- Chr 1221,176,804 (GRCh38)
- Highest magnitude
- 0.0Typical
- Tested on
- 23andMe, AncestryDNA, FamilyTreeDNA
- Minor allele frequency
- 41%
Genotypes
Plus strand, as in 23andMe and AncestryDNA files.
SNPedia records rs2306283 on the minus strand: (T;T). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Frequency
Share of each genotype in 11 HapMap populations.
- AverageA;A 15%
- European ancestry (Utah)A;A 36%
- Han Chinese (Beijing)A;A 4%
- Japanese (Tokyo)A;A 11%
- Yoruba (Nigeria)A;A 3%
- African ancestry (Southwest US)A;A 5%
- Chinese (Denver)A;A 6%
- Gujarati IndianA;A 20%
- Luhya (Kenya)A;A 4%
- Mexican ancestry (Los Angeles)A;A 40%
- Maasai (Kenya)A;A 5%
- TuscanA;A 30%
Related
Other SLCO1B1 SNPs
- rs4363657C;C17x increased myopathy risk for statin usersVery important
- rs4149056C;C17x myopathy risk for statin usersImportant
- rs2291075C;Ccommon in clinvarTypical
- rs4149013A;Acommon in complete genomicsTypical
- rs4149018T;Tcommon genotypeTypical
- rs7489119C;Ccommon genotypeTypical
- rs11045818G;Gcommon in clinvarTypical
- rs11045819C;Ccommon on affy axiom dataTypical
Notes
From SNPedia
Show notes, about 250 words
rs2306283 (Asn130Asp/N130D, A388G/388A>G) is a SNP within SLCO1B1 (Solute carrier organic anion transporter family member 1B1). A G at this location denotes the SLCO1B1*1B allele. among 8 healthy volunteers with *1B/*1B genotypes and 16 with the *1A/*1A genotype, *1B/*1B genotype associated with reduced plasma concentrations of repaglinide (but not nateglinide) consistent with increased hepatic uptake by SLCO1B1 (but w/ limited effects on nateglinide pharmacokinetics) news rs2306283 influences statin-related myopathy risk Genotyping panel for assessing response to cancer chemotherapy. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study. Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study. SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians. UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms versus neonatal hyperbilirubinemia: is there an association?
Source and license
Adapted from rs2306283 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.